---
schema_version: "secwatch.filing_event.v1"
accession: "0001516513-22-000070"
form_type: "8-K"
ticker: "DOCS"
cik: "0001516513"
company_name: "Doximity, Inc."
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T03:59:51.134747+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Doximity Q1 FY2023 revenue $90.6M (+25% YoY); appoints Phoebe Yang to board

## Summary
- Revenue $90.6M (+25% YoY); GAAP net income $22.4M (25% margin) vs $26.3M (36%) YoY.
- Adjusted EBITDA $33.5M (37% margin); non-GAAP diluted EPS $0.14 vs $0.11 YoY.
- Operating cash flow $44.8M (+35%); free cash flow $42.6M (+32%).
- Guidance: Q2 revenue $99.5-100.5M, adj. EBITDA $40-41M; FY2023 revenue $424-432M, adj. EBITDA $178-186M.
- Appointed Phoebe L. Yang (GM, AWS Healthcare) to board, replacing Gilbert Kliman; initial RSU grant $350K.

## SEC filing metadata
- accession: 0001516513-22-000070
- form_type: 8-K
- ticker: DOCS
- cik: 0001516513
- company_name: Doximity, Inc.
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516513/000151651322000070/0001516513-22-000070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516513/000151651322000070/docs-20220804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001516513-22-000070
- JSON: https://secwatch.observer/filing/0001516513-22-000070.json
- Plain text: https://secwatch.observer/filing/0001516513-22-000070.txt

## Key facts
- Executive change
  Phoebe L. Yang Watkin was appointed as Director at Doximity, Inc..
  - Action: appointed
  - Role: Director
  source text: On August 2, 2022, the Board appointed Phoebe L. Yang Watkin to serve as a Class III director of the Board, filling the vacancy created by the departure of Dr. Kliman from the Board, effective immediately, until the annual meeting of the Doximity’s stockholders to be held in calendar 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516513/000151651322000070/0001516513-22-000070-index.htm
- Executive change
  Gilbert Kliman departed as Director at Doximity, Inc..
  - Action: stepped down
  - Role: Director
  source text: On August 2, 2022, Gilbert Kliman, M.D. informed the board of directors (the "Board") of Doximity of his intention to step down from his role as a director on the Board, including his membership of the nominating and governance committee and the compensation committees of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516513/000151651322000070/0001516513-22-000070-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.